Beneficial effect of strict volume control on blood pressure and mortality in patients on hemodialysis: Commentary

Nature Clinical Practice Nephrology

Volumn 3, Issue 3, 2007, Pages 130-131

  Shaldon, Stanley ^a  

^a Department of Medicine ^*  (Monaco)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; ENALAPRIL; IRON; RECOMBINANT ERYTHROPOIETIN; SODIUM;

ADULT; ANEMIA; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; MORTALITY; NOTE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SODIUM RESTRICTION; SURVIVAL; THORAX RADIOGRAPHY; ULTRAFILTRATION; WEIGHT GAIN;

EID: 33847312150     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0403     Document Type: Note

References (5)

1. Kidney Disease Outcomes Quality Initiative (2004) Clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Guideline 6: dietary and other therapeutic lifestyle changes in adults. Am J Kidney Dis 43 (Suppl 1): s116
2. Kidney Disease Outcomes Quality Initiative (2006) Clinical practice guidelines for hemodialysis adequacy, update 2006. Guideline 5: Control of volume and blood pressure. Am J Kidney Dis 48 (Suppl 1): s33-S39
3. Comty C et al. (1964) Blood pressure control in patients with end stage renal disease treated by intermittent haemodialysis. Proc Eur Dial Transplant Assoc 1: 209-213
4. Shaldon S (2006) An explanation for the "lag phenomenon" in drug-free control of hypertension by dietary salt restriction in patients with chronic kidney disease on hemodialysis. Clin Nephrol 66: 1-2
5. + storage in the skin. Am J Physiol Heart Circ Physiol 287: H203-H208